Related Experiment Video
Updated: May 8, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential
Tomoyuki Ishiguro1, Kazuyuki Takeda2, Daisuke Takayanagi1
1Department of Medicine, Division of Medical Oncology, School of Medicine, Showa University, Tokyo, Japan.
Background/Aim:
The Kaplan-Meier curves for patients treated with immune checkpoint inhibitors (ICIs) display a small group of potentially-cured patients with long-term survival, creating a 'kangaroo-tail' shape of the survival curve. However, the mechanistic basis of this phenomenon and what occurs in patients whose cancer is resistant to ICIs remain unclear. The present study aimed to answer these questions.
Materials And Methods:
We analyzed mutations in mouse 4T1 mammary-gland-derived cancer cells expressing the hemagglutinin antigen (4T1-HA), which were grown in either wild-type mice or cytotoxic T-lymphocyte (CTL)-loaded immunocompromised mice (RAG-/- + ACT) under immune stress. These mutations were compared to those in 4T1-HA cells grown in RAG-/- mice without immune stress as a control.
Results:
The number of gene mutations, the tumor mutation burden (TMB) and microsatellite instability (MSI) scores were increased in the cancer cells under immune stress. The mutations in the antigen protein were such that the protein retained its immunogenicity and could still function as a neoantigen. Repeated immune recognition of additional neoantigens may lead to the kangaroo-tail survival phenomenon. The common genetic mutations of the analyzed 4T1-HA cells under immune stress included genes related to immune response. Analysis of alternative splicing of genes showed that are accumulated gene alterations under immune stress related to cancer-cell proliferation. Copy-number variation (CNV) analysis indicated that normal-antigen presentation and immune responses may be impaired under immune stress.
Conclusion:
Cancer cells, under immune stress, may acquire both immune escape capabilities and increased immunogenicity. This dual effect could lead to either resistance or response to ICIs, respectively.
Insights
Cancer cells under immune stress develop mutations that can lead to either immune escape or increased immunogenicity, explaining resistance or response to immune checkpoint inhibitors (ICIs). This immune stress response may also explain the "kangaroo-tail" survival curve phenomenon observed in patients treated with ICIs.
Area of Science:
- Immunology
- Cancer Biology
- Genetics
Background:
- Immune checkpoint inhibitors (ICIs) can lead to long-term survival in a subset of patients, characterized by a 'kangaroo-tail' survival curve.
- The underlying mechanisms driving this phenomenon and the behavior of ICI-resistant cancers remain poorly understood.
Purpose of the Study:
- To investigate the genetic and molecular changes in cancer cells under immune stress.
- To elucidate the mechanisms behind the 'kangaroo-tail' survival curve and cancer resistance to ICIs.
Main Methods:
- Analysis of mutations in 4T1 mammary-gland-derived cancer cells (4T1-HA) under immune stress in immunocompromised mice (RAG-/- + ACT) compared to controls (RAG-/- mice).
- Assessment of gene mutations, tumor mutation burden (TMB), microsatellite instability (MSI), neoantigen status, alternative splicing, and copy-number variation (CNV).
Main Results:
- Immune stress increased gene mutations, TMB, and MSI scores in cancer cells.
- Mutations preserved neoantigen function, potentially driving the 'kangaroo-tail' survival.
- Alterations in immune response genes and cancer proliferation genes were observed.
- CNV analysis suggested impaired antigen presentation and immune responses under immune stress.
Conclusions:
- Cancer cells adapt to immune stress by acquiring both immune escape mechanisms and enhanced immunogenicity.
- This dual adaptation can result in either resistance or response to immune checkpoint inhibitors (ICIs).
Related Concept Videos
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Psychoneuroimmunology: Diabetes and Cancer

